ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha-Fetoprotein (AFP) Biomarker Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25Z16693
Home | Market Reports | Health| Health Conditions| Cancer
Global Alpha Fetoprotein AFP Biomarker Market Research Report 2024
BUY CHAPTERS

Global Alpha-Fetoprotein (AFP) Biomarker Market Research Report 2025

Code: QYRE-Auto-25Z16693
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fujifilm
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
LabCorp
Thermo Fisher Scientific
Abcam
Bio-Techne
MyBioSource
RayBiotech
Cusabio
Elabscience Biotechnology
Abbexa

Alpha-Fetoprotein (AFP) Biomarker Market

The global market for Alpha-Fetoprotein (AFP) Biomarker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hepatocellular carcinoma (HCC) is the seventh most common cancer diagnosis worldwide with high associated mortality. HCC is a unique malignancy, as it typically arises in the setting of chronic liver disease in particular cirrhosis, with competing risks of liver failure, contributing to its low 5-year survival rates of 18%–20%. More than half of worldwide HCC-related deaths occur in Asia, due to endemic hepatitis B (HBV) infection. HCC incidence is rising in many Western countries due to the rising prevalence of nonalcoholic fatty liver disease, alcohol-related liver disease, and hepatitis C (HCV)-related complications despite the availability of direct acting antiviral therapies. The search for biomarkers in hepatocellular carcinoma continues despite recent approvals for immune checkpoint inhibitor combinations, tyrosine kinase inhibitors [TKIs], and antiangiogenesic agents. Biomarkers can be either predictive or prognostic and the only biomarker that has been used clinically is the prognostic biomarker α-fetoprotein (AFP).
North American market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Alpha-Fetoprotein (AFP) Biomarker in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Alpha-Fetoprotein (AFP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alpha-Fetoprotein (AFP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-Fetoprotein (AFP) Biomarker.
The Alpha-Fetoprotein (AFP) Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha-Fetoprotein (AFP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-Fetoprotein (AFP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Alpha-Fetoprotein (AFP) Biomarker Market Report

Report Metric Details
Report Name Alpha-Fetoprotein (AFP) Biomarker Market
Segment by Type
  • Liver Cancer
  • Testes Cancer
  • Ovarian Cancer
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, RayBiotech, CUSABIO, Elabscience Biotechnology, Abbexa
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Alpha-Fetoprotein (AFP) Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The main players in the Alpha-Fetoprotein (AFP) Biomarker Market are FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam, Bio-Techne, MyBiosource, RayBiotech, CUSABIO, Elabscience Biotechnology, Abbexa

What are the Application segmentation covered in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The Applications covered in the Alpha-Fetoprotein (AFP) Biomarker Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Alpha-Fetoprotein (AFP) Biomarker Market report?

Ans: The Types covered in the Alpha-Fetoprotein (AFP) Biomarker Market report are Liver Cancer, Testes Cancer, Ovarian Cancer, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liver Cancer
1.2.3 Testes Cancer
1.2.4 Ovarian Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Perspective (2020-2031)
2.2 Global Alpha-Fetoprotein (AFP) Biomarker Growth Trends by Region
2.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Alpha-Fetoprotein (AFP) Biomarker Market Dynamics
2.3.1 Alpha-Fetoprotein (AFP) Biomarker Industry Trends
2.3.2 Alpha-Fetoprotein (AFP) Biomarker Market Drivers
2.3.3 Alpha-Fetoprotein (AFP) Biomarker Market Challenges
2.3.4 Alpha-Fetoprotein (AFP) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue
3.1.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue (2020-2025)
3.1.2 Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alpha-Fetoprotein (AFP) Biomarker Revenue
3.4 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio
3.4.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2024
3.5 Global Key Players of Alpha-Fetoprotein (AFP) Biomarker Head office and Area Served
3.6 Global Key Players of Alpha-Fetoprotein (AFP) Biomarker, Product and Application
3.7 Global Key Players of Alpha-Fetoprotein (AFP) Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Type
4.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2026-2031)
5 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Application
5.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alpha-Fetoprotein (AFP) Biomarker Market Size (2020-2031)
6.2 North America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025)
6.4 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size (2020-2031)
7.2 Europe Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025)
7.4 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size (2020-2031)
9.2 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025)
9.4 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM
11.1.1 FUJIFILM Company Details
11.1.2 FUJIFILM Business Overview
11.1.3 FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Introduction
11.1.4 FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.1.5 FUJIFILM Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Introduction
11.2.4 Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.2.5 Eli Lilly and Company Recent Development
11.3 Fujirebio
11.3.1 Fujirebio Company Details
11.3.2 Fujirebio Business Overview
11.3.3 Fujirebio Alpha-Fetoprotein (AFP) Biomarker Introduction
11.3.4 Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.3.5 Fujirebio Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Introduction
11.4.4 Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.4.5 Roche Diagnostics Recent Development
11.5 Fapon Biotech
11.5.1 Fapon Biotech Company Details
11.5.2 Fapon Biotech Business Overview
11.5.3 Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Introduction
11.5.4 Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.5.5 Fapon Biotech Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Details
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Alpha-Fetoprotein (AFP) Biomarker Introduction
11.6.4 Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.6.5 Labcorp Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Introduction
11.7.4 Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Abcam
11.8.1 Abcam Company Details
11.8.2 Abcam Business Overview
11.8.3 Abcam Alpha-Fetoprotein (AFP) Biomarker Introduction
11.8.4 Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.8.5 Abcam Recent Development
11.9 Bio-Techne
11.9.1 Bio-Techne Company Details
11.9.2 Bio-Techne Business Overview
11.9.3 Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Introduction
11.9.4 Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.9.5 Bio-Techne Recent Development
11.10 MyBiosource
11.10.1 MyBiosource Company Details
11.10.2 MyBiosource Business Overview
11.10.3 MyBiosource Alpha-Fetoprotein (AFP) Biomarker Introduction
11.10.4 MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.10.5 MyBiosource Recent Development
11.11 RayBiotech
11.11.1 RayBiotech Company Details
11.11.2 RayBiotech Business Overview
11.11.3 RayBiotech Alpha-Fetoprotein (AFP) Biomarker Introduction
11.11.4 RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.11.5 RayBiotech Recent Development
11.12 CUSABIO
11.12.1 CUSABIO Company Details
11.12.2 CUSABIO Business Overview
11.12.3 CUSABIO Alpha-Fetoprotein (AFP) Biomarker Introduction
11.12.4 CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.12.5 CUSABIO Recent Development
11.13 Elabscience Biotechnology
11.13.1 Elabscience Biotechnology Company Details
11.13.2 Elabscience Biotechnology Business Overview
11.13.3 Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Introduction
11.13.4 Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.13.5 Elabscience Biotechnology Recent Development
11.14 Abbexa
11.14.1 Abbexa Company Details
11.14.2 Abbexa Business Overview
11.14.3 Abbexa Alpha-Fetoprotein (AFP) Biomarker Introduction
11.14.4 Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
11.14.5 Abbexa Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Fujifilm
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
LabCorp
Thermo Fisher Scientific
Abcam
Bio-Techne
MyBioSource
RayBiotech
Cusabio
Elabscience Biotechnology
Abbexa
List of Tables
 Table 1. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liver Cancer
 Table 3. Key Players of Testes Cancer
 Table 4. Key Players of Ovarian Cancer
 Table 5. Key Players of Others
 Table 6. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2020-2025)
 Table 10. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2026-2031)
 Table 12. Alpha-Fetoprotein (AFP) Biomarker Market Trends
 Table 13. Alpha-Fetoprotein (AFP) Biomarker Market Drivers
 Table 14. Alpha-Fetoprotein (AFP) Biomarker Market Challenges
 Table 15. Alpha-Fetoprotein (AFP) Biomarker Market Restraints
 Table 16. Global Alpha-Fetoprotein (AFP) Biomarker Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players (2020-2025)
 Table 18. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2024)
 Table 19. Ranking of Global Top Alpha-Fetoprotein (AFP) Biomarker Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Alpha-Fetoprotein (AFP) Biomarker, Headquarters and Area Served
 Table 22. Global Key Players of Alpha-Fetoprotein (AFP) Biomarker, Product and Application
 Table 23. Global Key Players of Alpha-Fetoprotein (AFP) Biomarker, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2020-2025)
 Table 27. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2026-2031)
 Table 29. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2020-2025)
 Table 31. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2026-2031)
 Table 33. North America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2026-2031) & (US$ Million)
 Table 48. FUJIFILM Company Details
 Table 49. FUJIFILM Business Overview
 Table 50. FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Product
 Table 51. FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 52. FUJIFILM Recent Development
 Table 53. Eli Lilly and Company Company Details
 Table 54. Eli Lilly and Company Business Overview
 Table 55. Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Product
 Table 56. Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 57. Eli Lilly and Company Recent Development
 Table 58. Fujirebio Company Details
 Table 59. Fujirebio Business Overview
 Table 60. Fujirebio Alpha-Fetoprotein (AFP) Biomarker Product
 Table 61. Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 62. Fujirebio Recent Development
 Table 63. Roche Diagnostics Company Details
 Table 64. Roche Diagnostics Business Overview
 Table 65. Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Product
 Table 66. Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 67. Roche Diagnostics Recent Development
 Table 68. Fapon Biotech Company Details
 Table 69. Fapon Biotech Business Overview
 Table 70. Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Product
 Table 71. Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 72. Fapon Biotech Recent Development
 Table 73. Labcorp Company Details
 Table 74. Labcorp Business Overview
 Table 75. Labcorp Alpha-Fetoprotein (AFP) Biomarker Product
 Table 76. Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 77. Labcorp Recent Development
 Table 78. Thermo Fisher Scientific Company Details
 Table 79. Thermo Fisher Scientific Business Overview
 Table 80. Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Product
 Table 81. Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 82. Thermo Fisher Scientific Recent Development
 Table 83. Abcam Company Details
 Table 84. Abcam Business Overview
 Table 85. Abcam Alpha-Fetoprotein (AFP) Biomarker Product
 Table 86. Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 87. Abcam Recent Development
 Table 88. Bio-Techne Company Details
 Table 89. Bio-Techne Business Overview
 Table 90. Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Product
 Table 91. Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 92. Bio-Techne Recent Development
 Table 93. MyBiosource Company Details
 Table 94. MyBiosource Business Overview
 Table 95. MyBiosource Alpha-Fetoprotein (AFP) Biomarker Product
 Table 96. MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 97. MyBiosource Recent Development
 Table 98. RayBiotech Company Details
 Table 99. RayBiotech Business Overview
 Table 100. RayBiotech Alpha-Fetoprotein (AFP) Biomarker Product
 Table 101. RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 102. RayBiotech Recent Development
 Table 103. CUSABIO Company Details
 Table 104. CUSABIO Business Overview
 Table 105. CUSABIO Alpha-Fetoprotein (AFP) Biomarker Product
 Table 106. CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 107. CUSABIO Recent Development
 Table 108. Elabscience Biotechnology Company Details
 Table 109. Elabscience Biotechnology Business Overview
 Table 110. Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Product
 Table 111. Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 112. Elabscience Biotechnology Recent Development
 Table 113. Abbexa Company Details
 Table 114. Abbexa Business Overview
 Table 115. Abbexa Alpha-Fetoprotein (AFP) Biomarker Product
 Table 116. Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025) & (US$ Million)
 Table 117. Abbexa Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Alpha-Fetoprotein (AFP) Biomarker Picture
 Figure 2. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Type: 2024 VS 2031
 Figure 4. Liver Cancer Features
 Figure 5. Testes Cancer Features
 Figure 6. Ovarian Cancer Features
 Figure 7. Others Features
 Figure 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Clinics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Alpha-Fetoprotein (AFP) Biomarker Report Years Considered
 Figure 14. Global Alpha-Fetoprotein (AFP) Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Alpha-Fetoprotein (AFP) Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region: 2024 VS 2031
 Figure 17. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players in 2024
 Figure 18. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2024
 Figure 20. North America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2020-2031)
 Figure 22. United States Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2020-2031)
 Figure 26. Germany Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2020-2031)
 Figure 34. China Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2020-2031)
 Figure 42. Mexico Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2020-2031)
 Figure 46. Turkey Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. FUJIFILM Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 50. Eli Lilly and Company Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 51. Fujirebio Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 52. Roche Diagnostics Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 53. Fapon Biotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 54. Labcorp Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 56. Abcam Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 57. Bio-Techne Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 58. MyBiosource Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 59. RayBiotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 60. CUSABIO Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 61. Elabscience Biotechnology Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 62. Abbexa Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global HCC Biomarker Market Research Report 2024
Global HCC Hepatocellular Carcinoma Biomarker Market Research Report 2024
Alpha fetoprotein Tumor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alpha Fetoprotein Quantitative Assay Kit Market Research Report 2024
Global Alpha Fetoprotein AFP ELISA Kit Market Research Report 2025
Global Alpha Fetoprotein Isoform Detection Market Research Report 2025
Global Alpha Fetoprotein AFP Tumor Marker Test Reagents Market Research Report 2024
Global Alpha Fetoprotein Testing Reagents Market Research Report 2024
Global Hepatocellular Carcinoma Targeted Drug Market Research Report 2025
Global Hepatoma Cell Targeted Drug Market Research Report 2025
Global Liver Cancer Therapeutics Market Insights Forecast to 2030
Global Liver Cancer Molecular Diagnostics Market Research Report 2024
Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Biomarker Market Research Report 2024
Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025
Global Alpha fetoprotein ELISA Kit Market Research Report 2024
Tumor Markers for Primary Liver Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Myeloid Leukemia Biomarker Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions